Science Daily - Heart Disease
DECEMBER 16, 2024
Significant complications associated with this condition include ischemic stroke, heart failure, myocardial infarction, chronic kidney disease, dementia and mortality. In the U.S., In a new review article scientists summarize the current evidence regarding the epidemiology, pathophysiology, diagnosis and management of AF.
Frontiers in Cardiovascular Medicine
JANUARY 23, 2024
Cardiogenic dementia is a cognitive impairment caused by heart dysfunction and has received increasing research attention. The prevention and treatment of cardiogenic dementia are essential to improve the quality of life, particularly in the elderly and aging population.
Dr. Paddy Barrett
AUGUST 30, 2024
Poor Sleep Might Eliminate The Benefits Of Exercise & Dementia. High levels of aerobic fitness are closely linked to lower rates of future dementia 1. Regular physical activity is arguably one of the biggest factors preventing dementia. When it comes to preventing dementia, this could not be truer. JAMA Intern Med.
Medical Xpress - Cardiology
OCTOBER 24, 2024
If untreated, dyslipidemia, especially high levels of LDL cholesterol ("bad" cholesterol), increases the risk of myocardial infarction, cerebral infarction, and dementia. Therefore, it is crucial to visit a medical institution and take appropriate measures when dyslipidemia is detected during a health checkup.
Stroke Journal
JANUARY 30, 2025
Cardiogenic dementia has been suggested to characterize patients suffering from cognitive decline after heart disease. Clinical and experimental evidence further suggest that 35%-65% of patients with myocardial ischemia are affected by CGI which include memory and global cognitive deficits.
Stroke Journal
JANUARY 30, 2025
Comorbidities such as PAD, depression, and other mental health disorders predict readmission after elective CAS, while heart failure, AKI, CAD, COPD, CKD, lipid disorders, DM, obesity, anemia, cancer, and dementia are predictive after elective CEA.
Stroke Journal
FEBRUARY 1, 2024
While the epsilon (ε) 4 variants within theAPOEgene have been extensively investigated as a risk factor for dementia and stroke,APOEε4 carriers have not been thoroughly studied as an at-risk population. Participants with prior stroke, transient ischemic attack (TIA) or myocardial infarction (MI) were excluded.
Expert insights. Personalized for you.
112 
Let's personalize your content